Long-term results of irradiation for paraganglioma

Aaron Krych, Robert L. Foote, Paul D. Brown, Yolanda Isabel Garces, Michael J. Link

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Purpose: The management of paragangliomas is controversial. Observation, surgery, external-beam radiotherapy (EBRT), and stereotactic radiosurgery (SRS) may, alone or in combination, be appropriate, depending on the size and extent of the tumor, previous treatment, and patient age, general health, and neurologic condition. Few data exist regarding long-term tumor control and late effects after EBRT or SRS. Methods and Materials: We performed a retrospective review of all patients treated with EBRT or SRS for paraganglioma at our institution between 1967 and 1994. The endpoints of the study were tumor control and late complications. Results: The 33 patients in this study had a median follow-up of 13 years (range, 4 months to 36 years). The 10-year tumor control rate was 92% (95% confidence interval, 75-98%). At the last follow-up visit, no patient had developed a radiation-induced malignancy. Conclusion: External-beam RT and SRS are safe and effective for enlarging and/or symptomatic paragangliomas. The risk of developing a delayed radiation-induced malignancy after EBRT or SRS is low. This risk must be weighed against the significant immediate and permanent risk of cranial nerve deficits if the tumor is untreated or is surgically resected. This risk must also be weighed against the immediate but low risk of surgical mortality.

Original languageEnglish (US)
Pages (from-to)1063-1066
Number of pages4
JournalInternational Journal of Radiation Oncology Biology Physics
Volume65
Issue number4
DOIs
StatePublished - Jul 15 2006

Fingerprint

Paraganglioma
Radiosurgery
tumors
radiation therapy
irradiation
Radiotherapy
Neoplasms
mortality
nerves
radiation
Radiation
surgery
health
confidence
Cranial Nerves
intervals
Nervous System
expansion
Observation
Confidence Intervals

Keywords

  • Paraganglioma
  • Radiotherapy
  • Stereotactic radiosurgery

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Long-term results of irradiation for paraganglioma. / Krych, Aaron; Foote, Robert L.; Brown, Paul D.; Garces, Yolanda Isabel; Link, Michael J.

In: International Journal of Radiation Oncology Biology Physics, Vol. 65, No. 4, 15.07.2006, p. 1063-1066.

Research output: Contribution to journalArticle

Krych, Aaron ; Foote, Robert L. ; Brown, Paul D. ; Garces, Yolanda Isabel ; Link, Michael J. / Long-term results of irradiation for paraganglioma. In: International Journal of Radiation Oncology Biology Physics. 2006 ; Vol. 65, No. 4. pp. 1063-1066.
@article{bb699ec7835c4fcb911c2e5feaec58be,
title = "Long-term results of irradiation for paraganglioma",
abstract = "Purpose: The management of paragangliomas is controversial. Observation, surgery, external-beam radiotherapy (EBRT), and stereotactic radiosurgery (SRS) may, alone or in combination, be appropriate, depending on the size and extent of the tumor, previous treatment, and patient age, general health, and neurologic condition. Few data exist regarding long-term tumor control and late effects after EBRT or SRS. Methods and Materials: We performed a retrospective review of all patients treated with EBRT or SRS for paraganglioma at our institution between 1967 and 1994. The endpoints of the study were tumor control and late complications. Results: The 33 patients in this study had a median follow-up of 13 years (range, 4 months to 36 years). The 10-year tumor control rate was 92{\%} (95{\%} confidence interval, 75-98{\%}). At the last follow-up visit, no patient had developed a radiation-induced malignancy. Conclusion: External-beam RT and SRS are safe and effective for enlarging and/or symptomatic paragangliomas. The risk of developing a delayed radiation-induced malignancy after EBRT or SRS is low. This risk must be weighed against the significant immediate and permanent risk of cranial nerve deficits if the tumor is untreated or is surgically resected. This risk must also be weighed against the immediate but low risk of surgical mortality.",
keywords = "Paraganglioma, Radiotherapy, Stereotactic radiosurgery",
author = "Aaron Krych and Foote, {Robert L.} and Brown, {Paul D.} and Garces, {Yolanda Isabel} and Link, {Michael J.}",
year = "2006",
month = "7",
day = "15",
doi = "10.1016/j.ijrobp.2006.02.020",
language = "English (US)",
volume = "65",
pages = "1063--1066",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Long-term results of irradiation for paraganglioma

AU - Krych, Aaron

AU - Foote, Robert L.

AU - Brown, Paul D.

AU - Garces, Yolanda Isabel

AU - Link, Michael J.

PY - 2006/7/15

Y1 - 2006/7/15

N2 - Purpose: The management of paragangliomas is controversial. Observation, surgery, external-beam radiotherapy (EBRT), and stereotactic radiosurgery (SRS) may, alone or in combination, be appropriate, depending on the size and extent of the tumor, previous treatment, and patient age, general health, and neurologic condition. Few data exist regarding long-term tumor control and late effects after EBRT or SRS. Methods and Materials: We performed a retrospective review of all patients treated with EBRT or SRS for paraganglioma at our institution between 1967 and 1994. The endpoints of the study were tumor control and late complications. Results: The 33 patients in this study had a median follow-up of 13 years (range, 4 months to 36 years). The 10-year tumor control rate was 92% (95% confidence interval, 75-98%). At the last follow-up visit, no patient had developed a radiation-induced malignancy. Conclusion: External-beam RT and SRS are safe and effective for enlarging and/or symptomatic paragangliomas. The risk of developing a delayed radiation-induced malignancy after EBRT or SRS is low. This risk must be weighed against the significant immediate and permanent risk of cranial nerve deficits if the tumor is untreated or is surgically resected. This risk must also be weighed against the immediate but low risk of surgical mortality.

AB - Purpose: The management of paragangliomas is controversial. Observation, surgery, external-beam radiotherapy (EBRT), and stereotactic radiosurgery (SRS) may, alone or in combination, be appropriate, depending on the size and extent of the tumor, previous treatment, and patient age, general health, and neurologic condition. Few data exist regarding long-term tumor control and late effects after EBRT or SRS. Methods and Materials: We performed a retrospective review of all patients treated with EBRT or SRS for paraganglioma at our institution between 1967 and 1994. The endpoints of the study were tumor control and late complications. Results: The 33 patients in this study had a median follow-up of 13 years (range, 4 months to 36 years). The 10-year tumor control rate was 92% (95% confidence interval, 75-98%). At the last follow-up visit, no patient had developed a radiation-induced malignancy. Conclusion: External-beam RT and SRS are safe and effective for enlarging and/or symptomatic paragangliomas. The risk of developing a delayed radiation-induced malignancy after EBRT or SRS is low. This risk must be weighed against the significant immediate and permanent risk of cranial nerve deficits if the tumor is untreated or is surgically resected. This risk must also be weighed against the immediate but low risk of surgical mortality.

KW - Paraganglioma

KW - Radiotherapy

KW - Stereotactic radiosurgery

UR - http://www.scopus.com/inward/record.url?scp=33745202831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745202831&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2006.02.020

DO - 10.1016/j.ijrobp.2006.02.020

M3 - Article

C2 - 16682153

AN - SCOPUS:33745202831

VL - 65

SP - 1063

EP - 1066

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -